MDS-ES 3rd Speech and Swallowing in Parkinson’s Disease School

prague speech 2019

MDS-ES 3rd Speech and Swallowing in Parkinson’s Disease School

Prague, Czech Republic – July 26-27, 2019

Course Directors

Jan Rusz – Charles University, Prague, Czech Republic

Elina Tripoliti - National Hospital for Neurology and Neurosurgery, London, United Kingdom

The MDS-ES 3rd Speech and Swallowing in Parkinson's Disease School takes place in Prague, Czech Republic, July 26-27, 2019.Course Description

Dysarthria in Parkinson’s disease (PD) is primarily characterized by hypophonia and dysprosody. It can worsen during the disease progression with a poor and variable response to pharmacological and/or neurosurgical treatments. Hypophonia in PD usually responds well to intensive speech therapies, but it is not always offered to PD patients. Managing swallowing and saliva problems effectively can have a positive impact on quality of life.

The main objective of MDS-ES 3rd Speech and Swallowing in Parkinson’s Disease School is to provide an opportunity for speech clinicians to be informed about clinical management of Parkinsonism, as well as to provide the most recent knowledge about clinical and research aspects of speech and swallowing in PD and atypical parkinsonism.

The program is designed as a 2-day school in order to provide an opportunity for small group workshops. The training sessions with patients will provide practical knowledge on how to assess and treat speech and swallowing problems in PD.

Recommended Audience

This course is intended for speech therapists, speech pathologists, neurologists, ENTs, heath professionals specialized in Parkinson’s disease management, speech scientists, and neuroscientists.

Learning Objectives 
  • Discuss the neurological bases of speech and swallowing function in PD and atypical parkinsonism;
  • ​Assess speech and swallowing dysfunction with due consideration on its implications for social participation;
  • Plan a rehabilitation program for speech and/or swallowing impairments in PD patients, considering recent technological advances and patient-reported outcome measures
  • Identify how and when speech therapy can be fully effective according to disease progression and in association with medical and/or surgical treatments.


Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine
Kateřinská 32, 121 08 Prague 2
Czech Republic

Visa Statement

MDS is able to provide participants with a Letter of Support and any course-related documentation needed to assist in obtaining a visa. Please note that MDS is unable to contact the Embassy on your behalf. It is the responsibility of each participant to make the necessary arrangements related to this process. However, if the official handling your application needs further clarification, please have them contact


The MDS-ES 3rd Speech and Swallowing in Parkinson's Disease School is compliant with MedTech Europe Code of Ethical Business Practice.



We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including and This cookie policy only covers the primary and domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice